Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07456865 · ClinicalTrials.gov registry record · NA
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
A NA study of Urge Urinary Incontinence, sponsored by MedtronicNeuro.
- Recruiting
- Registry status
- NA
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT07456865: Recruiting NA study of Urge Urinary Incontinence, sponsored by MedtronicNeuro.
NCT07456865 is a NA study of Urge Urinary Incontinence that is actively recruiting participants, run by MedtronicNeuro. The registered enrollment target is 256 participants, above the 129-participant average among 4 other Urge Urinary Incontinence trials with a reported enrollment target (98% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07456865, a NA study of Urge Urinary Incontinence, is actively recruiting participants, sponsored by MedtronicNeuro.
- RECRUITING
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI
Primary Outcome
The primary endpoint is the UUI responder rate, which is defined as the proportion of subjects experiencing at least 50% improvement in daily UUI compared to baseline. The UUI responder rate will be measured annually through 60 months.
Conditions Studied
Interventions
- DEVICE Altaviva™ system
Study Locations (1)
Pennsylvania
- Institute for Female Pelvic Medicine and Reconstructive Surgery - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2026-03-17 |
| Est. Completion | 2032-11 |
| Phase | NA |
What NCT07456865 shows while recruiting
NCT07456865 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, above the 129-participant average among 4 other Urge Urinary Incontinence trials with a reported enrollment target (98% higher).
The record links to 1 condition, with Urge Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Altaviva™ system is the first listed.
NCT07456865 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07456865 about?
NCT07456865 is a clinical study titled "Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device". The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI
What is the current status of trial NCT07456865?
This trial is currently recruiting. It is a NA study. The enrollment target is 256 participants. The study started on 2026-03-17. Estimated completion is 2032-11.
What conditions does trial NCT07456865 study?
This clinical trial studies the following conditions: Urge Urinary Incontinence.
What interventions are being tested in trial NCT07456865?
The interventions under investigation include: Altaviva™ system (DEVICE).
Who is sponsoring clinical trial NCT07456865?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07456865 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urge Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI